Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROXSTAR registry of roxadustat for anemia in chronic kidney disease
ChiCTR2100046322Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of roxadustat in anemia of renal disease, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Treatment-emergent adverse events, Serious adverse events and 2 more. Started Oct 2020; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR2100046322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046322.